Testing Firm's Warning About Ferries Unheeded

LONDON—Last month's sinking of the English Channel ferry the Herald of Free Enterprise has focused attention on a group of scientists and engineers whose unique expertise has been neglected in the rash of recent privatizations in Britain. Companies operating similar "roll-on, roll-off" (or Ro-Ro) ferries have not responded to efforts by the managers of the now privately owned company British Maritime Technology (BMT) to point out the design weaknesses of such craft. One consequence is that

Written byJohn Stansell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Companies operating similar "roll-on, roll-off" (or Ro-Ro) ferries have not responded to efforts by the managers of the now privately owned company British Maritime Technology (BMT) to point out the design weaknesses of such craft. One consequence is that a modern test tank, with facilities to simulate ocean wave conditions, has been mothballed.

The speed with which the Herald of Free Enterprise turned over has brought to light the fact that BMT's specialists, following an investigation of the capsizing of another Ro-Ro ferry, had warned that it could happen again. BMT had suggested that the 1982 capsizing of the ferry European Gateway following a collision pointed to serious design weaknesses in such ships and had offered to mount a two-year research program.

David Goodridge, managing director of BMT, told a newspaper here that not one of 24 ferry operators had accepted his offer, made last November. When questioned, many operators ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies